Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum β-lactamases in York, UK

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 3, 2004, Pages 628-633

  Munday, C J ^a   Whitehead, G M ^b   Todd, N J ^b   Campbell, M ^c   Hawkey, Peter M ^a,d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b YORK HOSPITAL   (United Kingdom)

^c GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^d BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

Enterobacteriaceae; ESBLs; Salmonella

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; DNA; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CITROBACTER FREUNDII; COMMUNICABLE DISEASE; CONTROLLED STUDY; DIFFUSION; DNA SEQUENCE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; FECES ANALYSIS; FECES MICROFLORA; GENETIC ANALYSIS; GENETIC VARIABILITY; HOSPITAL INFECTION; KLEBSIELLA; NONHUMAN; POLYMERASE CHAIN REACTION; SALMONELLA; SCREENING; UNITED KINGDOM;

BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GREAT BRITAIN; HUMANS; MICROBIAL SENSITIVITY TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VARIATION (GENETICS);

EID: 4644330155     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh397     Document Type: Article

References (35)

1. Livermore, D. M. (1995). β-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 8, 557-84.
2. Brenwald, N. P., Jevons, G., Andrews, J. M. et al. (2003). An outbreak of a CTX-M-type β-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum β-lactamases. Journal of Antimicrobial Chemotherapy 51, 195-6.
3. Mushtaq, S., Woodford, N., Potz, N. et al. (2003). Detection of CTX-M-15 extended-spectrum β-lactamase in the United Kingdom. Journal of Antimicrobial Chemotherapy 52, 528-9.
4. Bonnet, R. (2004). Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrobial Agents and Chemotherapy 48, 1-14.
5. Piddock, L. J., Walters, R. N., Jin, Y. F. et al. (1997). Prevalence and mechanism of resistance to 'third-generation' cephalosporins in clinically relevant isolates of Enterobacteriaceae from 43 hospitals in the UK, 1990-1991. Journal of Antimicrobial Chemotherapy 39, 177-87.
6. Munday, C. J., Xiong, J., Li, C. et al. (2004). Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People's Republic of China. International Journal of Antimicrobial Agents 23, 175-80.
7. Radice, M., Power, P., Di Conza, J. et al. (2002). Early dissemination of CTX-M-derived enzymes in South America. Antimicrobial Agents and Chemotherapy 46, 602-4.
8. Quinteros, M., Radice, M., Gardella, N. et al. (2003). Extended-spectrum β-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrobial Agents and Chemotherapy 47, 2864-7.
9. Alobwede, I., M'Zali, F. H., Livermore, D. M. et al. (2003). CTX-M extended-spectrum β-lactamase arrives in the UK. Journal of Antimicrobial Chemotherapy 51, 470-1.
10. Jarlier, V., Nicolas, M. H., Fournier, G. et al. (1988). Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Reviews in Infectious Diseases 10, 867-78.
11. Hawkey, P. M. & Lewis, D. (2004). Medical Bacteriology - A Practical Approach, 2nd edn. Oxford University Press, Oxford, UK.
12. Andrews, J. M. (2001). BSAC standardized disc susceptibility testing method. Journal of Antimicrobial Chemotheraphy 48, Suppl. S1, 43-57.
13. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA.
14. National Committee for Clinical Performance Standards. (2002). Performance Standards for Antimicrobial Susceptibility Testing: Approved Standard M100-S12. NCCLS, Wayne, PA, USA.
15. OXA-1 genes in Enterobacteriaceae. FEMS Microbiological Letters 223, 147-51.
16. Chanawong, A., M'Zali, F. H., Heritage, J. et al. (2001). Discrimination of SHV β-lactamase genes by restriction site insertion-PCR. Antimicrobial Agents and Chemotherapy 45, 2110-4.
17. Munday, C. J., Ensor, V. M., Liu, W. E. et al. (2004). Multiplex PCR detection of CTX-M gene. Clinical Microbiology and Infection 10, Suppl. 3, 248.
18. CTX-M-9. Antimicrobial Agents and Chemotherapy 46, 2656-61.
19. Yamasaki, K., Komatsu, M., Yamashita, T. et al. (2003). Production of CTX-M-3 extended-spectrum β-lactamase and IMP-1 metallo β-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan. Journal of Antimicrobial Chemotherapy 51, 631-8.
20. Yu, W. L., Winokur, P. L., Von Stein, D. L. et al. (2002). First description of Klebsiella pneumoniae harboring CTX-M β -lactamases (CTX-M-14 and CTX-M-3) in Taiwan. Antimicrobial Agents and Chemotherapy 46, 1098-100.
21. Canton, R., Oliver, A., Coque, T. M. et al. (2002). Epidemiology of extended-spectrum β-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. Journal of Clinical Microbiology 40, 1237-43.
22. Chanawong, A., M'Zali, F. H., Heritage, J. et al. (2001). SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum beta-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand. Journal of Antimicrobial Chemotherapy 48, 839-52.
23. Eckert, C., Gautier, V., Saladin-Allard, M. et al. (2004). Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrobial Agents and Chemotherapy 48, 1249-55.
24. Chanawong, A., M'Zali, F. H., Heritage, J. et al. (2002). Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrobial Agents and Chemotherapy 46, 630-7.
25. Mulvey, M. R., Bryce, E., Boyd, D. et al. (2004). Ambler class A extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrobial Agents and Chemotherapy 48, 1204-14.
26. Paterson, D. L., Hujer, K. M., Hujer, A. M. et al. (2003). Extended-spectrum β-lactamases in Klebsiella pneumoniae blood-stream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases. Antimicrobial Agents and Chemotherapy 47, 3554-60.
27. Mulvey, M. R., Soule, G., Boyd, D. et al. (2003). Characterization of the first extended-spectrum β -lactamase-producing Salmonella isolate identified in Canada. Journal of Clinical Microbiology 41, 460-2.
28. Baraniak, A., Sadowy, E., Hryniewicz, W. et al. (2002). Two different extended-spectrum β-lactamases (ESBLs) in one of the first ESBL-producing salmonella isolates in Poland. Journal of Clinical Microbiology 40, 1095-7.
29. Miriagou, V., Filip, R., Coman, G. et al. (2002). Expanded-spectrum cephalosporin-resistant salmonella strains in Romania. Journal of Clinical Microbiology 40, 4334-6.
30. Villa, L., Mammina, C., Miriagou, V. et al. (2002). Multidrug and broad-spectrum cephalosporin resistance among Salmonella enterica serotype Enteritidis clinical isolates in southern Italy. Journal of Clinical Microbiology 40, 2662-5.
31. Romero, L., Lopez, L., Martinez-Martinez, L. et al. (2004). Characterization of the first CTX-M-14-producing Salmonella enterica serotype Enteritidis isolate. Journal of Antimicrobial Chemotherapy 53, 1113-4.
32. Daza, R., Gutierrez, J. & Piedrola, G. (2001). Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. International Journal of Antimicrobial Agents 18, 211-5.
33. Colodner, R., Rock, W., Chazan, B. et al. (2004). Risk factors for the development of extended-spectrum β -lactamase-producing bacteria in nonhospitalized patients. European Journal of Clinical Microbiology and Infectious Diseases 23, 163-7.
34. Borer, A., Gilad, J., Menashe, G. et al. (2002). Extended-spectrum β-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel. Medical Science Monitor 8, CR44-7.
35. Arpin, C., Dubois, V., Coulange, L. et al. (2003). Extended-spectrum β-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrobial Agents and Chemotherapy 47, 3506-14.